The microglial P2Y receptor as a therapeutic target for neurodegenerative diseases.

Transl Neurodegener

Department of Biochemistry, University of Cambridge, Cambridge, UK.

Published: September 2024

Neurodegenerative diseases are associated with chronic neuroinflammation in the brain, which can result in microglial phagocytosis of live synapses and neurons that may contribute to cognitive deficits and neuronal loss. The microglial P2Y receptor (P2YR) is a G-protein coupled receptor, which stimulates microglial phagocytosis when activated by extracellular uridine diphosphate, released by stressed neurons. Knockout or inhibition of P2YR can prevent neuronal loss in mouse models of Alzheimer's disease (AD), Parkinson's disease, epilepsy, neuroinflammation and aging, and prevent cognitive deficits in models of AD, epilepsy and aging. This review summarises the known roles of P2YR in the physiology and pathology of the brain, and its potential as a therapeutic target to prevent neurodegeneration and other brain pathologies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380353PMC
http://dx.doi.org/10.1186/s40035-024-00438-5DOI Listing

Publication Analysis

Top Keywords

microglial p2y
8
p2y receptor
8
therapeutic target
8
neurodegenerative diseases
8
microglial phagocytosis
8
cognitive deficits
8
neuronal loss
8
microglial
4
receptor therapeutic
4
target neurodegenerative
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!